| Product Name | MF | CAS | Details |
|---|
| N-(4-bromo-3-methylphenyl)-4-(2-fluorophenyl)piperazine-1-carboxamide | C18H19BrFN3O | 1024132-75-9 | Details |
| 1,3,5-O-Methylidyne-myo-inositol | C7H10O6 | 98510-20-4 | Details |
| (R)-(+)-2-Methyl-CBS-oxazaborolidine | C18H20BNO | 112022-83-0 | Details |
| 3-(2-Hydroxyphenoxy)-1,2-propanediol | C9H12O4 | 19826-87-0 | Details |
| NK 314 | C22H18ClNO4 | 208237-49-4 | Details |
| 7,7-dimethyl-1-(((4-(5-(trifluoromethyl)(2-pyridyl))piperazinyl)sulfonyl)methyl)bicyclo[2.2.1]heptan-2-one | C20H26F3N3O3S | 1048915-59-8 | Details |
| 2-Amino-2-(3-fluorophenyl)propanoic acid | C9H10FNO2 | 328-81-4 | Details |
| N-Phenylpyrazin-2-amine | C10H9N3 | 13134-34-4 | Details |
| Natalizumab LC46-58 KSN deimmunised | Details |
| 2-(4-Bromophenyl)tetrahydrofuran | C10H11BrO | 194725-15-0 | Details |
| Methyl 4-(2-chloroethyl)benzoate | C10H11ClO2 | 65787-72-6 | Details |
| Boc-Lys(Cl-Z)-OH | C19H27ClN2O6 | 54613-99-9 | Details |
| Ubiquitin human | 60267-61-0 | Details |
| H-LNIDLLWSV-OH | Details |
| 4-Chlorobenzamide | C7H6ClNO | 619-56-7 | Details |
| Norepinephrine sulfonic acid | C8H11NO5S | 24159-36-2 | Details |
| Byakangelicol | C17H16O6 | 26091-79-2 | Details |
| Cyclorasin 9A54 | Details |
| N-(4-Carbamothioylphenyl)propanamide | C10H12N2OS | 950094-51-6 | Details |
| 2-Bromo-6-methylpyridine-3-carboxylic acid | C7H6BrNO2 | 1060810-09-4 | Details |
| 3’-Bromo-2’,3’-dideoxy-5-methyluridine | C10H13BrN2O4 | 99785-51-0 | Details |
| Methyl 2,5-dibromo-4-pyridinecarboxylate | C7H5Br2NO2 | 1214378-73-0 | Details |
| BTBD12 Blocking Peptide | Details |
| H-WHWLQLKPGQPMY-OH | C82H114N20O17S | 59401-28-4 | Details |
| Uracil-d4 | C4D4N2O2 | 24897-55-0 | Details |
| BIX 02189 | C27H28N4O2 | 1094614-85-3 | Details |
| Ethyl 4-((3-chloro-4-methoxybenzyl)amino)-2-(methylthio)pyrimidine-5-carboxylate | C16H18ClN3O3S | 330785-81-4 | Details |
| PF-4840154 | C26H38N6O2 | 1332708-14-1 | Details |
| Kaempferol-3-sophoroside-7-glucoside | C33H40O21 | 55136-76-0 | Details |
| trans-Resveratrol 3-O-b-D-glucuronide | C20H22O8 | 27208-80-6 | Details |
| Glycidol | C3H6O2 | 556-52-5 | Details |
| 4-Chloro-2-cyclopentylpyrido[3,4-d]pyrimidine | C12H12ClN3 | 1437385-42-6 | Details |
| 3-Bromo-5-chlorothiophene-2-carbaldehyde | C5H2BrClOS | 403640-46-0 | Details |
| Poly(propylene carbonate) | C4H6O3 | 25511-85-7 | Details |
| 4-{5H,6H,7H,8H,9H-[1,2,4]Triazolo[4,3-a]azepin-3-yl}aniline | C13H16N4 | 109220-81-7 | Details |
| Chondroitin sulfate sodium salt | C42H57N3Na6O43S3X2 | 9082-07-9 | Details |
| (E)-Doxepin-d3 | C19H21NO | 3607-34-9 | Details |
| Methyl 2-chloro-2-(3,5-dichlorophenyl)acetate | C9H7Cl3O2 | 1250898-69-1 | Details |
| VNI | C26H19Cl2N5O2 | 1246770-52-4 | Details |
| Ac-CPTNDKAKAGNKP-NH2 PAB-404-871Y | Details |
| 8-Amino-2,3,4,5-tetrahydro-1H-2-benzazepin-1-one | C10H12N2O | 1022972-01-5 | Details |
| PIN4 antibody | Details |
| BBC3 antibody | Details |
| trans-6-Boc-octahydropyrrolo[3,4-b][1,4]oxazine ee | C11H20N2O3 | 138026-93-4 | Details |
| 6-(Methylsulfanyl)hexanenitrile | C7H13NS | 72931-29-4 | Details |
| JDQ-443 | C29H28ClN7O | 2653994-08-0 | Details |
| tert-Butyl 3-[(2-chloropyrimidin-4-yl)amino]piperidine-1-carboxylate | C14H21ClN4O2 | 945895-44-3 | Details |
| 7-Hydroxyquinoline | C9H7NO | 580-20-1 | Details |
| UVI 3003 | C28H36O4 | 847239-17-2 | Details |
| tert-Butyl 5,6-dichloropyridine-3-carboxylate | C10H11Cl2NO2 | 1011476-27-9 | Details |
| Methyl 4'-hydroxy-[1,1'-biphenyl]-4-carboxylate | C14H12O3 | 40501-41-5 | Details |
| Esermethole | C14H20N2O | 65166-97-4 | Details |
| 3-Ethyl-1-methylpiperazin-2-one | C7H14N2O | 1214796-54-9 | Details |
| [(2R)-1-[1-(3-Chlorophenyl)-6-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl]pyrrolidin-2-yl]methanol | C17H18ClN5O | 1461689-24-6 | Details |
| 2-(Difluoromethoxy)-4-propoxybenzoic acid | C11H12F2O4 | 1154276-48-8 | Details |
| 2'-Deoxy-2'-fluorocytidine-5'-triphosphate sodium, 100mM aqueous solution | Details |
| 2-Acetamido-1,3,4,6-tetra-O-benzyl-2-deoxy-b-D-thioglucopyranose | C36H40NO5S | Details |
| Human VEGFR1 ELISA kit | Details |
| SSRP1 antibody | Details |
| {2H,3H-[1,4]Dioxino[2,3-c]pyridin-7-yl}methanamine dihydrochloride | C8H11ClN2O2 | 2059932-02-2 | Details |
| 1-Isobutyl-1H-pyrazol-5-amine | C7H13N3 | 3524-18-3 | Details |
| Tofacitinib impurity 69 | C15H23N5 | 2183519-70-0 | Details |
| 5,6-Dehydro-tigecycline | C29H37N5O8 | 1633815-62-9 | Details |
| Ethyl 2-hydroxy-2-(oxolan-3-yl)acetate | C8H14O4 | 221546-88-9 | Details |
| 4'-(But-1-yl)-2'-methylacetanilide | C13H19NO | 143360-00-3 | Details |
| [4-(Difluoromethoxy)-3-fluorophenyl]methanamine | C8H8F3NO | 954388-61-5 | Details |
| LBP Blocking Peptide | Details |
| 2-Azaspiro[4.4]nonane-1-carboxylic acid hydrochloride | C9H16ClNO2 | 2378501-53-0 | Details |
| (1-Methyl-1H-imidazol-2-yl)(1-phenylcyclopropyl)methanamine dihydrochloride | 2138010-63-4 | Details |
| [Tyr63] PTH (63-84), human | C103H172N28O37 | Details |
| (d(CH2)51,Tyr(Me)2,Arg8)-Vasopressin trifluoroacetate salt | C52H74N14O12S2 | 73168-24-8 | Details |
| 1-(Thiophen-2-yl)cyclohexane-1-carbonitrile | C11H13NS | 99856-75-4 | Details |
| 4-(Morpholine-4-sulfonyl)-1H-pyrrole-2-carboxylic acid | C9H12N2O5S | 869464-92-6 | Details |
| 4-Bromo-2,2-dimethyloxolane | C6H11BrO | 1193-08-4 | Details |
| 7-((4'-L-Alaninamido)-rac-3'-hydroxybutyloxy) coumarin | Details |
| 3,4,6-Trichloro-1-benzothiophene-2-carboxylic acid | C9H3Cl3O2S | 34576-90-4 | Details |
| 1-(Cyclopentylmethyl)piperidin-4-amine | C11H22N2 | 64306-78-1 | Details |
| 4-Iodo-1,2-thiazol-3-amine hydrochloride | 2219407-30-2 | Details |
| 3-Bromo-5H,6H,7H,8H,9H-[1,2,4]triazolo[4,3-a]azepine | C7H10BrN3 | 1379357-77-3 | Details |
| Brexpiprazole impurity 10 | C16H15NO2 | 15116-41-3 | Details |
| CD3 antibody (PE) | Details |
| H-CSEVNL-OH | Details |
| 3-Chloro-N-[(4-nitrophenyl)methyl]propane-1-sulfonamide | C10H13ClN2O4S | 258856-32-5 | Details |
| 2-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)acetonitrile | C6H4N2O2 | 1184639-97-1 | Details |
| 2-(2-Methylpropyl)-1H-imidazole-4-carboxylic acid hydrochloride | C8H12N2O2.HCl | 1375473-67-8 | Details |
| rac-2-[(1R,3R)-3-Aminocyclobutyl]acetic acid hydrochloride | C6H12ClNO2 | 1523606-40-7 | Details |
| rac-(1R,2S)-2-tert-Butylcyclopropan-1-amine hydrochloride | C7H16ClN | 2343963-72-2 | Details |
| HDHD2 protein (His tag) | Details |
| 4-Fluoro-1H-pyrazole-3-carboxylic acid | C4H3FN2O2 | 881668-91-3 | Details |
| H-RRETQL-OH | Details |
| 1-{3-[(4-Fluorophenyl)methoxy]phenyl}piperazine | C17H19FN2O | 1082454-50-9 | Details |
| IDO1-IN-5 | C23H25FN2O3 | 2166616-75-5 | Details |
| 3-[(5-Nitrofuran-2-yl)formamido]propanoic acid | C8H8N2O6 | 746608-27-5 | Details |
| rac-Cyclohexylalaninol hydrochloride | C9H20ClNO | 82867-37-6 | Details |
| 6-Bromo-4-chloro-2,3-dimethylquinoline | C11H9BrClN | 1203-70-9 | Details |
| cis-6-Boc-octahydropyrrolo[3,4-b]morpholine | C11H20N2O3 | 138027-02-8 | Details |
| H-LLLASPR^-OH | Details |
| Cardiac Troponin ITC-complex | Details |
| H-YTNWIQK^-OH | Details |
| 5-Bromomethyl-3-methyl-isoxazole+ | C5H6BrNO | 36958-61-9 | Details |
| Product Total： Product Page： | ||||
| 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 | ||||